NCT04439942View on ClinicalTrials.gov

4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Hypertrophic CardiomyopathyObstructionEchocardiography
Interventions
OTHER

cardiac magnetic resonance imaging (MRI)

Cardiac MRI is a mandatory examination for Hypertrophic cardiomyopathy patients as it provides important information about the presence of fibrosis which is also directly associated with sudden cardiac death.

Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT04439942 - 4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter